# NexPoint Real Estate Finance, Inc.: financial statements, quarterly

NREF · NYSE · CIK 1786248 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nref.md) · [Financials](/companies/nref/financials.md) · [Filings](/companies/nref/filings.md) · [Insiders](/companies/nref/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nref/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [13.2](/filings/0001786248-23-000019.md) | [13.1 d](/filings/0001786248-24-000004.md) | [11.2](/filings/0001786248-24-000011.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(17.1)](/filings/0001786248-24-000022.md) | [17.9 d](/filings/0001193125-26-134672.md) | [(14.6)](/filings/0001786248-25-000010.md) | [12.1](/filings/0001786248-25-000016.md) | [23.3](/filings/0001628280-25-052000.md) | [15.2 d](/filings/0001193125-26-134672.md) | [26.0](/filings/0001193125-26-226577.md) | [22.3](/filings/0001193125-26-347504.md) | [50.9](/filings/0001628280-25-052000.md) | [24.0 d](/filings/0001193125-26-134672.md) | [22.6](/filings/0001193125-26-226577.md) | [17.3](/filings/0001193125-26-347504.md) |
| Diluted EPS | $ per share | [(0.90)](/filings/0001786248-24-000022.md) | not reported | [(0.83)](/filings/0001786248-25-000010.md) | [0.40](/filings/0001786248-25-000016.md) | [0.74](/filings/0001628280-25-052000.md) | not reported | [0.70](/filings/0001193125-26-226577.md) | [0.54](/filings/0001193125-26-347504.md) | [1.14](/filings/0001628280-25-052000.md) | not reported | [0.42](/filings/0001193125-26-226577.md) | [0.29](/filings/0001193125-26-347504.md) |
| Basic EPS | $ per share | [(0.90)](/filings/0001786248-24-000022.md) | not reported | [(0.83)](/filings/0001786248-25-000010.md) | [0.43](/filings/0001786248-25-000016.md) | [0.92](/filings/0001628280-25-052000.md) | not reported | [0.94](/filings/0001193125-26-226577.md) | [0.69](/filings/0001193125-26-347504.md) | [1.98](/filings/0001628280-25-052000.md) | not reported | [0.54](/filings/0001193125-26-226577.md) | [0.29](/filings/0001193125-26-347504.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.0](/filings/0001786248-23-000019.md) | [13.8](/filings/0001786248-25-000004.md) | [13.5](/filings/0001786248-24-000011.md) | [4.3](/filings/0001786248-24-000017.md) | [34.7](/filings/0001786248-24-000022.md) | [3.9](/filings/0001193125-26-134672.md) | [19.2](/filings/0001786248-25-000010.md) | [9.1](/filings/0001786248-25-000016.md) | [17.9](/filings/0001628280-25-052000.md) | [31.1](/filings/0001193125-26-347504.md) | [22.6](/filings/0001193125-26-226577.md) | [6.4](/filings/0001193125-26-347504.md) |
| Total assets | $m | [6,886](/filings/0001786248-23-000019.md) | [7,018](/filings/0001786248-25-000004.md) | [7,085](/filings/0001786248-24-000011.md) | [6,575](/filings/0001786248-24-000017.md) | [5,686](/filings/0001786248-24-000022.md) | [5,416](/filings/0001193125-26-134672.md) | [5,399](/filings/0001786248-25-000010.md) | [5,402](/filings/0001786248-25-000016.md) | [5,278](/filings/0001628280-25-052000.md) | [5,321](/filings/0001193125-26-347504.md) | [5,235](/filings/0001193125-26-226577.md) | [5,368](/filings/0001193125-26-347504.md) |
| Total liabilities | $m | [6,452](/filings/0001786248-23-000019.md) | [6,573](/filings/0001786248-25-000004.md) | [6,637](/filings/0001786248-24-000011.md) | [6,093](/filings/0001786248-24-000017.md) | [5,153](/filings/0001786248-24-000022.md) | [4,844](/filings/0001193125-26-134672.md) | [4,778](/filings/0001786248-25-000010.md) | [4,720](/filings/0001786248-25-000016.md) | [4,503](/filings/0001628280-25-052000.md) | [4,489](/filings/0001193125-26-347504.md) | [4,385](/filings/0001193125-26-226577.md) | [4,505](/filings/0001193125-26-347504.md) |
| Long-term debt | $m | [1,215](/filings/0001786248-23-000019.md) | [1,272](/filings/0001786248-24-000004.md) | [843](/filings/0001786248-24-000011.md) | [861](/filings/0001786248-24-000017.md) | [816](/filings/0001786248-24-000022.md) | [799](/filings/0001786248-25-000004.md) | [832](/filings/0001786248-25-000010.md) | [816](/filings/0001786248-25-000016.md) | [721](/filings/0001628280-25-052000.md) | [771](/filings/0001193125-26-134672.md) | not reported | not reported |
| Shareholders' equity | $m | [345](/filings/0001786248-24-000022.md) | [347](/filings/0001193125-26-134672.md) | [327](/filings/0001786248-25-000016.md) | [327](/filings/0001628280-25-052000.md) | [336](/filings/0001628280-25-052000.md) | [336](/filings/0001193125-26-347504.md) | [344](/filings/0001193125-26-347504.md) | [348](/filings/0001193125-26-347504.md) | [375](/filings/0001628280-25-052000.md) | [388](/filings/0001193125-26-347504.md) | [389](/filings/0001193125-26-347504.md) | [380](/filings/0001193125-26-347504.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.0 d](/filings/0001786248-24-000022.md) | [3.1 d](/filings/0001193125-26-134672.md) | [17.7](/filings/0001786248-25-000010.md) | [(7.5) d](/filings/0001786248-25-000016.md) | [14.7 d](/filings/0001628280-25-052000.md) | [4.4 d](/filings/0001193125-26-134672.md) | [16.0](/filings/0001193125-26-226577.md) | [3.3 d](/filings/0001193125-26-347504.md) | [8.1 d](/filings/0001628280-25-052000.md) | [(4.5) d](/filings/0001193125-26-134672.md) | [9.4](/filings/0001193125-26-226577.md) | [(6.0) d](/filings/0001193125-26-347504.md) |
| Dividends paid | $m | [11.8 d](/filings/0001786248-24-000022.md) | [12.6 d](/filings/0001193125-26-134672.md) | [8.7](/filings/0001786248-25-000010.md) | [8.7 d](/filings/0001786248-25-000016.md) | [7.8 d](/filings/0001628280-25-052000.md) | [9.7 d](/filings/0001193125-26-134672.md) | [8.8](/filings/0001193125-26-226577.md) | [8.9 d](/filings/0001193125-26-347504.md) | [8.4 d](/filings/0001628280-25-052000.md) | [9.4 d](/filings/0001193125-26-134672.md) | [12.3](/filings/0001193125-26-226577.md) | [9.4 d](/filings/0001193125-26-347504.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.7](/filings/0001786248-23-000019.md) | [22.7](/filings/0001786248-24-000011.md) | [23.1](/filings/0001786248-24-000017.md) | [23.1](/filings/0001786248-24-000022.md) | [24.9](/filings/0001786248-25-000010.md) | [27.8](/filings/0001786248-25-000016.md) | [30.5](/filings/0001628280-25-052000.md) | [36.0](/filings/0001193125-26-226577.md) | [39.5](/filings/0001193125-26-347504.md) | [43.9](/filings/0001628280-25-052000.md) | [51.5](/filings/0001193125-26-226577.md) | [54.0](/filings/0001193125-26-347504.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,848,029 at 2026-08-12, from the cover of the [10-Q filed 2026-08-13](/filings/0001193125-26-347504.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.